PL337725A1 - Inhibitors of proteases - Google Patents
Inhibitors of proteasesInfo
- Publication number
- PL337725A1 PL337725A1 PL98337725A PL33772598A PL337725A1 PL 337725 A1 PL337725 A1 PL 337725A1 PL 98337725 A PL98337725 A PL 98337725A PL 33772598 A PL33772598 A PL 33772598A PL 337725 A1 PL337725 A1 PL 337725A1
- Authority
- PL
- Poland
- Prior art keywords
- proteases
- inhibitors
- Prior art date
Links
- 102000035195 Peptidases Human genes 0.000 title 1
- 108091005804 Peptidases Proteins 0.000 title 1
- 239000004365 Protease Substances 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Enzymes And Modification Thereof (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4506797P | 1997-04-29 | 1997-04-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL337725A1 true PL337725A1 (en) | 2000-08-28 |
Family
ID=21935831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL98337725A PL337725A1 (en) | 1997-04-29 | 1998-04-29 | Inhibitors of proteases |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1019046A4 (en) |
| JP (1) | JP2002504097A (en) |
| KR (1) | KR20010020391A (en) |
| CN (1) | CN1261276A (en) |
| AR (1) | AR012622A1 (en) |
| AU (1) | AU7365198A (en) |
| BR (1) | BR9809333A (en) |
| CA (1) | CA2287989A1 (en) |
| CO (1) | CO4940477A1 (en) |
| HU (1) | HUP0001294A3 (en) |
| IL (1) | IL132629A0 (en) |
| MA (1) | MA26487A1 (en) |
| NO (1) | NO995268L (en) |
| PE (1) | PE69099A1 (en) |
| PL (1) | PL337725A1 (en) |
| TR (1) | TR199902703T2 (en) |
| WO (1) | WO1998048799A1 (en) |
| ZA (1) | ZA983522B (en) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001526230A (en) | 1997-12-19 | 2001-12-18 | スミスクライン・ビーチャム・コーポレイション | Heteroaryl-substituted imidazole compounds, pharmaceutical compositions and uses thereof |
| US6100282A (en) * | 1998-01-02 | 2000-08-08 | Hoffman-La Roche Inc. | Thiazole derivatives |
| MA26618A1 (en) * | 1998-04-09 | 2004-12-20 | Smithkline Beecham Corp | PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF MALARIA |
| US6858617B2 (en) | 1998-05-26 | 2005-02-22 | Smithkline Beecham Corporation | Substituted imidazole compounds |
| WO2000025791A1 (en) | 1998-11-04 | 2000-05-11 | Smithkline Beecham Corporation | Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
| CO5150165A1 (en) * | 1998-11-13 | 2002-04-29 | Smithkline Beecham Plc | PROTEASE INHIBITORS: KATEPSIN K TYPE |
| US20030144175A1 (en) | 1998-12-23 | 2003-07-31 | Smithkline Beecham Corporation | Protease inhibitors |
| US6534498B1 (en) | 1999-11-10 | 2003-03-18 | Smithkline Beecham Corporation | Protease inhibitors |
| US6596715B1 (en) | 1999-11-10 | 2003-07-22 | Smithkline Beecham Corporation | Protease inhibitors |
| US6583137B1 (en) | 1999-11-10 | 2003-06-24 | Smithkline Beecham Corporation | Protease inhibitors |
| JP2003514900A (en) | 1999-11-23 | 2003-04-22 | スミスクライン・ビーチャム・コーポレイション | 3,4-Dihydro- (1H) -quinazolin-2-one compounds as CSBP / p38 kinase inhibitors |
| ES2249309T3 (en) | 1999-11-23 | 2006-04-01 | Smithkline Beecham Corp | COMPOUNDS OF 3,4-DIHIDRO- (1H) QUINAZOLIN-2-ONA AS INHIBITORS OF CSBP / P39 KINASA. |
| AU1650501A (en) * | 1999-12-03 | 2001-06-12 | Ono Pharmaceutical Co. Ltd. | 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient |
| US6797720B2 (en) | 1999-12-03 | 2004-09-28 | Ono Pharmaceutical Co., Ltd. | 1,3,4-oxadiazoline derivative and an agent comprising its derivative as active ingredient |
| US7235551B2 (en) | 2000-03-02 | 2007-06-26 | Smithkline Beecham Corporation | 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| CA2404206A1 (en) | 2000-03-21 | 2001-09-27 | Smithkline Beecham Corporation | Protease inhibitors |
| WO2003062192A1 (en) | 2002-01-17 | 2003-07-31 | Smithkline Beecham Corporation | Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors |
| DE60227008D1 (en) * | 2002-07-04 | 2008-07-17 | Aventis Pharma Sa | NEW THIOPHENACYLHYDRAZINODERIVATES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS A MEDICAMENT, PHARMACEUTICAL COMPOSITIONS AND NEW APPLICATIONS |
| KR100962972B1 (en) | 2002-07-26 | 2010-06-09 | 주식회사유한양행 | 1-phenylpiperidin-3-one derivatives and preparation method thereof |
| WO2011015524A2 (en) * | 2009-08-03 | 2011-02-10 | Bayer Cropscience Ag | Fungicide heterocycles derivatives |
| CA2882088C (en) * | 2012-08-23 | 2021-11-23 | Alios Biopharma, Inc. | Compounds for the treatment of paramoxyvirus viral infections |
| CN114716426A (en) | 2013-08-21 | 2022-07-08 | 詹森生物制药有限公司 | antiviral compound |
| MA41614A (en) | 2015-02-25 | 2018-01-02 | Alios Biopharma Inc | ANTIVIRAL COMPOUNDS |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0934291A1 (en) * | 1995-10-30 | 1999-08-11 | Smithkline Beecham Corporation | Protease inhibitors |
-
1998
- 1998-04-24 MA MA25047A patent/MA26487A1/en unknown
- 1998-04-27 PE PE1998000320A patent/PE69099A1/en not_active Application Discontinuation
- 1998-04-28 ZA ZA983522A patent/ZA983522B/en unknown
- 1998-04-29 JP JP54738998A patent/JP2002504097A/en active Pending
- 1998-04-29 IL IL13262998A patent/IL132629A0/en unknown
- 1998-04-29 AU AU73651/98A patent/AU7365198A/en not_active Abandoned
- 1998-04-29 EP EP98920926A patent/EP1019046A4/en not_active Withdrawn
- 1998-04-29 KR KR1019997010013A patent/KR20010020391A/en not_active Withdrawn
- 1998-04-29 CO CO98023491A patent/CO4940477A1/en unknown
- 1998-04-29 AR ARP980101999A patent/AR012622A1/en unknown
- 1998-04-29 TR TR1999/02703T patent/TR199902703T2/en unknown
- 1998-04-29 BR BR9809333-9A patent/BR9809333A/en not_active IP Right Cessation
- 1998-04-29 HU HU0001294A patent/HUP0001294A3/en unknown
- 1998-04-29 WO PCT/US1998/008740 patent/WO1998048799A1/en not_active Application Discontinuation
- 1998-04-29 CN CN98806641A patent/CN1261276A/en active Pending
- 1998-04-29 CA CA002287989A patent/CA2287989A1/en not_active Abandoned
- 1998-04-29 PL PL98337725A patent/PL337725A1/en unknown
-
1999
- 1999-10-28 NO NO995268A patent/NO995268L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1019046A1 (en) | 2000-07-19 |
| BR9809333A (en) | 2000-07-04 |
| HUP0001294A2 (en) | 2001-04-28 |
| ZA983522B (en) | 1998-10-29 |
| CN1261276A (en) | 2000-07-26 |
| MA26487A1 (en) | 2004-12-20 |
| JP2002504097A (en) | 2002-02-05 |
| IL132629A0 (en) | 2001-03-19 |
| EP1019046A4 (en) | 2002-11-27 |
| HUP0001294A3 (en) | 2001-06-28 |
| WO1998048799A1 (en) | 1998-11-05 |
| AR012622A1 (en) | 2000-11-08 |
| AU7365198A (en) | 1998-11-24 |
| KR20010020391A (en) | 2001-03-15 |
| NO995268L (en) | 1999-11-15 |
| CA2287989A1 (en) | 1998-11-05 |
| CO4940477A1 (en) | 2000-07-24 |
| PE69099A1 (en) | 1999-09-26 |
| TR199902703T2 (en) | 2000-02-21 |
| NO995268D0 (en) | 1999-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP9701054A0 (en) | Inhibitors of cycteine protease | |
| PL341762A1 (en) | Precursors of aspartil protease inhibitors | |
| ZA983843B (en) | Protease inhibitors | |
| PL334846A1 (en) | Sulphamidic inhibitors of metaloproteases | |
| PL336589A1 (en) | Serinic protease inhibitors | |
| PL337725A1 (en) | Inhibitors of proteases | |
| PL323710A1 (en) | Reversible inhibitors of cysteinic protease | |
| PL326508A1 (en) | Protease inhibitors | |
| PL342113A1 (en) | Sulphonamidic derivatives useful as precursors of aspartil protease inhibitors | |
| PL339738A1 (en) | Novel lactamic inhibitors of metaloproteinases | |
| ZA983841B (en) | Protease inhibitors | |
| PL328307A1 (en) | Serinic protease inhibitors | |
| HU0900792D0 (en) | Use of renin-angiotensin inhibitors | |
| PL334975A1 (en) | Application of gasto-intestinal lipase inhibitors | |
| PL328665A1 (en) | Inhibitors of serinic protease | |
| ZA983762B (en) | Protease inhibitors | |
| EP0923535A4 (en) | Inhibitors of cysteine protease | |
| ZA988479B (en) | Protease inhibitors | |
| PL328875A1 (en) | Serinic protease inhibitors | |
| PL328223A1 (en) | Aspartil protease inhibitors | |
| HUP0101640A3 (en) | Certain thoil inhibitors of endothelin-converting enzyme | |
| ZA983065B (en) | Inhibitors of protein farnesyltranferase | |
| ZA988064B (en) | Protease inhibitors | |
| EP0975612A4 (en) | Protease inhibitors | |
| ZA983097B (en) | Protease inhibitors |